First Comparison of Amulet and Watchman FLX LAA Closure Devices Found Similar Outcomes

Results from the SWISS-APERO Trial reported at TCT 2021 and published simultaneously in Circulation

Cureus, Acute Ischemic Stroke Due to Incomplete Endothelialization of a Left Atrial Appendage Occluder

TCT DAIC

Amulet LAA Closure Device Has Fewer Leaks Than Watchman: Does It Matter?

Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX LAAC Device

TCT DAIC

Left Atrial Appendage (LAA) Occluders

Transcatheter LAA Closure Transcatheter Left Atrial Appendage Closure

Left Atrial Appendage Closure for Stroke Risk Reduction in Nonvalvular Atrial Fibrillation - The Cardiology Advisor

Percutaneous Left Atrial Appendage Occlusion Therapy: Evolution and Growing Evidence

TCT DAIC

Diagnostic and Interventional Cardiology

of comparison between WATCHMAN FLX and WATCHMAN 2.5 in profiles and